Header Logo

Connection

WOLFGANG WINKELMAYER to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Clinical Trials, Phase III as Topic.
WOLFGANG WINKELMAYER
Connection Strength
0.050
Clinical Trials, Phase III as Topic
  1. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Am J Hematol. 2022 09; 97(9):1178-1188.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.